» Articles » PMID: 31783627

Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways

Overview
Journal Biomolecules
Publisher MDPI
Date 2019 Dec 1
PMID 31783627
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac glycosides (CGs) are a diverse family of naturally derived compounds having a steroid and glycone moiety in their structures. CG molecules inhibit the α-subunit of ubiquitous transmembrane protein Na/K-ATPase and are clinically approved for the treatment of cardiovascular diseases. Recently, the CGs were found to exhibit selective cytotoxic effects against cancer cells, raising interest in their use as anti-cancer molecules. In this current study, we explored the underlying mechanism responsible for the anti-cancer activity of Lanatoside C against breast (MCF-7), lung (A549), and liver (HepG2) cancer cell lines. Using Real-time PCR, western blot, and immunofluorescence studies, we observed that (i) Lanatoside C inhibited cell proliferation and induced apoptosis in cell-specific and dose-dependent manner only in cancer cell lines; (ii) Lanatoside C exerts its anti-cancer activity by arresting the G2/M phase of cell cycle by blocking MAPK/Wnt/PAM signaling pathways; (iii) it induces apoptosis by inducing DNA damage and inhibiting PI3K/AKT/mTOR signaling pathways; and finally, (iv) molecular docking analysis shows significant evidence on the binding sites of Lanatoside C with various key signaling proteins ranging from cell survival to cell death. Our studies provide a novel molecular insight of anti-cancer activities of Lanatoside C in human cancer cells.

Citing Articles

Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting.

Qiang M, Chen Z, Liu H, Dong J, Gong K, Zhang X Front Pharmacol. 2025; 16:1516583.

PMID: 40041495 PMC: 11877449. DOI: 10.3389/fphar.2025.1516583.


Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics.

Paul J, Azmal M, Haque Shohan M, Mrinmoy M, Haque A, Talukder O Heliyon. 2025; 11(2):e41897.

PMID: 39897896 PMC: 11783009. DOI: 10.1016/j.heliyon.2025.e41897.


Extrachromosomal circular DNA and their roles in cancer progression.

Zheng S, Li Y, Wang L, Wei Q, Wei M, Yu T Genes Dis. 2024; 12(1):101202.

PMID: 39534571 PMC: 11554924. DOI: 10.1016/j.gendis.2023.101202.


Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity.

Mahmoud M, Ahmed E, Ragab H, Eltelbany R, Hassan R RSC Adv. 2024; 14(41):30346-30363.

PMID: 39318461 PMC: 11420776. DOI: 10.1039/d4ra04036h.


Pseudolaric Acid B Inhibits FLT4-induced Proliferation and Migration in Non-small Cell Lung Cancer.

Lei P, Liang J, Su X, Gao J, Ren B, Ma X Anticancer Agents Med Chem. 2024; 24(19):1419-1430.

PMID: 39192640 DOI: 10.2174/0118715206313028240819103933.


References
1.
Zanchett Schneider N, Cerella C, Oliveira Simoes C, Diederich M . Anticancer and Immunogenic Properties of Cardiac Glycosides. Molecules. 2017; 22(11). PMC: 6150164. DOI: 10.3390/molecules22111932. View

2.
Xue L, Zhang W, Fan Q, Wang L . Licochalcone A inhibits PI3K/Akt/mTOR signaling pathway activation and promotes autophagy in breast cancer cells. Oncol Lett. 2018; 15(2):1869-1873. PMC: 5774519. DOI: 10.3892/ol.2017.7451. View

3.
Kang M, Kim M, Kim W, Um J, Shin Y, Song J . Lanatoside C suppressed colorectal cancer cell growth by inducing mitochondrial dysfunction and increased radiation sensitivity by impairing DNA damage repair. Oncotarget. 2016; 7(5):6074-87. PMC: 4868741. DOI: 10.18632/oncotarget.6832. View

4.
Phang C, Karsani S, Sethi G, Malek S . Flavokawain C Inhibits Cell Cycle and Promotes Apoptosis, Associated with Endoplasmic Reticulum Stress and Regulation of MAPKs and Akt Signaling Pathways in HCT 116 Human Colon Carcinoma Cells. PLoS One. 2016; 11(2):e0148775. PMC: 4747580. DOI: 10.1371/journal.pone.0148775. View

5.
Kim S, Kim C, Bae H, Lee J, Baek S, Nam D . 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways. Mol Carcinog. 2014; 54(10):1132-46. DOI: 10.1002/mc.22184. View